Redwine Karen M, James Laura P, O'Riordan MaryAnn, Sullivan Janice E, Blumer Jeffrey L
aDepartment of Pediatrics, Division of Pediatric Nephrology bDepartment of Pediatrics, Section of Clinical Pharmacology and Toxicology, University of Arkansas for Medical Sciences & Arkansas Children's Hospital, Little Rock, Arkansas cDepartment of Pediatrics, Division of Pediatric Critical Care, Case Western Reserve University Hospitals, Cleveland dDepartment of Pediatrics, University of Toledo, Toledo, Ohio Departments of ePediatrics fPharmacology/Toxicology, Divisions of Pediatric Critical Care and the Kosair Charities Pediatric Clinical Research Unit, University of Louisville, Louisville, Kentucky gNational Institute of Child Health and Human Development, Rockville, Maryland, USA.
Blood Press Monit. 2015 Oct;20(5):295-8. doi: 10.1097/MBP.0000000000000132.
Ambulatory blood pressure monitoring techniques provide unique advantages for diagnosing hypertension, although few devices have been independently validated in the pediatric population.
We sought to validate the accuracy of ambulatory blood pressure monitoring with the Spacelabs 90217 monitor in children using a modified British Hypertension Society protocol.
A total of 112 children, aged between 6 and 17 years, completed the study at one of the three participating centers. Overall, the monitor earned an 'A' for systolic blood pressure and 'B' for diastolic blood pressure. It performed slightly better among 6-12 year olds (A/A) compared with 13-17 year olds (A/B).
We conclude that the Spacelabs 90217 monitor is an appropriate monitor for use in children who are 6 years of age or older.
动态血压监测技术在诊断高血压方面具有独特优势,尽管很少有设备在儿科人群中得到独立验证。
我们试图采用改良的英国高血压学会方案,验证Spacelabs 90217监测仪在儿童动态血压监测中的准确性。
共有112名年龄在6至17岁之间的儿童在三个参与中心之一完成了该研究。总体而言,该监测仪在收缩压方面获得“A”级,在舒张压方面获得“B”级。与13至17岁儿童(A/B)相比,其在6至12岁儿童中表现稍好(A/A)。
我们得出结论,Spacelabs 90217监测仪适用于6岁及以上的儿童。